ARCHIVES

FDA Approves Xeloda For Breast Cancer After Failure Of Anthracycline Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 35 | September 28, 2001

Download PDF Visit The Full Archive

Related Articles

Freement Lists Steps For Dealing With Disadvantaged

September 7, 1990

NCI Cooperative Group Trials Approved Last Month By CTEP

March 26, 2010

NCI Places Hold On Genentech Drug Trials, Citing Disagreement Over Intellectual Property Provisions.

March 12, 2010

NCI Funds; Ad Hoc Group Approves NCCTG Renewal

September 18, 1981

Social Networks Influence Decision To Quit Smoking

May 30, 2008

In Brief: Foundation Gives Georgetown $2.9 Million For Pediatric Lab, To Be Headed By Cairo

February 6, 1998